Tredje AP-fonden’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.4M | Buy |
48,138
+1,768
| +4% | +$338K | 0.05% | 322 |
|
|
2026
Q1 | $8.5M | Buy |
+46,370
| New | +$8.54M | 0.05% | 349 |
|
|
2025
Q2 | – | Sell |
-50,000
| Closed | -$6.84M | – | 382 |
|
|
2025
Q1 | $6.84M | Buy |
+50,000
| New | +$7.15M | 0.06% | 147 |
|
|
2024
Q1 | – | Sell |
-13,263
| Closed | -$3.43M | – | 490 |
|
|
2023
Q4 | $3.43M | Sell |
13,263
-37,120
| -74% | -$9.12M | 0.04% | 258 |
|
|
2023
Q3 | $12.9M | Hold |
50,383
| – | – | 0.19% | 99 |
|
|
2023
Q2 | $14.4M | Hold |
50,383
| – | – | 0.2% | 98 |
|
|
2023
Q1 | $14M | Buy |
50,383
+41,286
| +454% | +$11.4M | 0.22% | 98 |
|
|
2022
Q4 | $2.52M | Buy |
9,097
+700
| +8% | +$198K | 0.04% | 322 |
|
|
2022
Q3 | $2.24M | Sell |
8,397
-20,667
| -71% | -$4.39M | 0.05% | 318 |
|
|
2022
Q2 | $5.93M | Hold |
29,064
| – | – | 0.15% | 128 |
|
|
2022
Q1 | $6.12M | Hold |
29,064
| – | – | 0.12% | 145 |
|
|
2021
Q4 | $6.97M | Buy |
29,064
+27,564
| +1,838% | +$7.09M | 0.13% | 137 |
|
|
2021
Q3 | $424K | Hold |
1,500
| – | – | 0.01% | 255 |
|
|
2021
Q2 | $519K | Sell |
1,500
-18,778
| -93% | -$5.69M | 0.01% | 186 |
|
|
2021
Q1 | $5.67M | Hold |
20,278
| – | – | 0.14% | 121 |
|
|
2020
Q4 | $4.96M | Hold |
20,278
| – | – | 0.13% | 123 |
|
|
2020
Q3 | $5.75M | Hold |
20,278
| – | – | 0.19% | 90 |
|
|
2020
Q2 | $5.42M | Sell |
20,278
-10,165
| -33% | -$3.06M | 0.22% | 84 |
|
|
2020
Q1 | $9.63M | Sell |
30,443
-2,829
| -9% | -$859K | 0.5% | 48 |
|
|
2019
Q4 | $9.87M | Sell |
33,272
-3,498
| -10% | -$971K | 0.5% | 46 |
|
|
2019
Q3 | $8.56M | Sell |
36,770
-2,453
| -6% | -$571K | 0.41% | 56 |
|
|
2019
Q2 | $9.17M | Buy |
39,223
+6,100
| +18% | +$1.41M | 0.44% | 52 |
|
|
2019
Q1 | $7.83M | Buy |
33,123
+1,761
| +6% | +$555K | 0.41% | 60 |
|
|
2018
Q4 | $9.44M | Sell |
31,362
-16,106
| -34% | -$5.14M | 0.58% | 41 |
|
|
2018
Q3 | $16.8M | Sell |
47,468
-8,947
| -16% | -$3.08M | 0.81% | 28 |
|
|
2018
Q2 | $16.4M | Buy |
56,415
+9,321
| +20% | +$2.62M | 0.57% | 45 |
|
|
2018
Q1 | $12.9M | Buy |
47,094
+439
| +0.9% | +$136K | 0.46% | 50 |
|
|
2017
Q4 | $14.9M | Buy |
46,655
+120
| +0.3% | +$38.5K | 0.5% | 46 |
|
|
2017
Q3 | $14.6M | Buy |
46,535
+1,200
| +3% | +$355K | 0.52% | 44 |
|
|
2017
Q2 | $12.3M | Hold |
45,335
| – | – | 0.46% | 48 |
|
|
2017
Q1 | $12.4M | Hold |
45,335
| – | – | 0.49% | 46 |
|
|
2016
Q4 | $12.9M | Sell |
45,335
-1,210
| -3% | -$359K | 0.54% | 43 |
|
|
2016
Q3 | $14.6M | Sell |
46,545
-3,824
| -8% | -$1.13M | 0.66% | 32 |
|
|
2016
Q2 | $12.2M | Sell |
50,369
-3,426
| -6% | -$903K | 0.54% | 43 |
|
|
2016
Q1 | $14.4M | Buy |
53,795
+7,450
| +16% | +$1.97M | 0.66% | 38 |
|
|
2015
Q4 | $14.2M | Buy |
46,345
+31,193
| +206% | +$8.96M | 0.91% | 23 |
|
|
2015
Q3 | $4.42M | Sell |
15,152
-1,652
| -10% | -$546K | 0.43% | 57 |
|
|
2015
Q2 | $6.79M | Buy |
+16,804
| New | +$6.74M | 0.54% | 45 |
|
Other funds holding BIIB
Tredje AP-fonden's BIIB Position: Q2 2026 in Review
Tredje AP-fonden increased its Biogen (BIIB) stake by 3.8% in Q2 2026, buying an estimated $338K and bringing the position to 48,138 shares worth $10.4M. The position accounts for 0.05% of the portfolio, ranked #322.
Tredje AP-fonden first reported a position in BIIB in Q2 2015 and has held it in 38 quarters since. The position peaked at $16.8M in Q3 2018. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Tredje AP-fonden held 48,138 shares of Biogen worth $10.4M as of Q2 2026.
- Tredje AP-fonden bought 1,768 Biogen shares in Q2 2026, an estimated $338K.
- Biogen made up 0.05% of Tredje AP-fonden's portfolio in Q2 2026, its #322 holding.
- Tredje AP-fonden first reported a position in Biogen in Q2 2015 and has held it in 38 quarters since.
- Tredje AP-fonden's Biogen position peaked at $16.8M in Q3 2018.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.